BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23656966)

  • 1. Credibility and comprehension of healthy volunteers in lengthy inpatient drug studies.
    Apseloff G; Kitzmiller JP; Tishler CL
    Am J Ther; 2013; 20(3):257-60. PubMed ID: 23656966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
    Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
    Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to volunteer comprehension of informed consent for a clinical trial.
    Kaewpoonsri N; Okanurak K; Kitayaporn D; Kaewkungwal J; Vijaykadga S; Thamaree S
    Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):996-1004. PubMed ID: 17333746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do our patients understand about their trial participation? Assessing patients' understanding of their informed consent consultation about randomised clinical trials.
    Behrendt C; Gölz T; Roesler C; Bertz H; Wünsch A
    J Med Ethics; 2011 Feb; 37(2):74-80. PubMed ID: 21098797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehension and recall from the informed consent process by phase I healthy volunteers before dose administration.
    Tadros R; Caughey GE; Johns S; Shakib S
    Clin Trials; 2019 Jun; 16(3):283-289. PubMed ID: 30818994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recall of informed consent information by healthy volunteers in clinical trials.
    Fortun P; West J; Chalkley L; Shonde A; Hawkey C
    QJM; 2008 Aug; 101(8):625-9. PubMed ID: 18487271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthy participants in phase I clinical trials: the quality of their decision to take part.
    Rabin C; Tabak N
    J Clin Nurs; 2006 Aug; 15(8):971-9. PubMed ID: 16879541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.
    Fisher JA; McManus L; Cottingham MD; Kalbaugh JM; Wood MM; Monahan T; Walker RL
    PLoS Med; 2018 Nov; 15(11):e1002698. PubMed ID: 30457992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The views of patients and healthy volunteers on participation in clinical trials: an exploratory survey study.
    Chu SH; Jeong SH; Kim EJ; Park MS; Park K; Nam M; Shim JY; Yoon YR
    Contemp Clin Trials; 2012 Jul; 33(4):611-9. PubMed ID: 22405971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of disease severity on the informed consent process in clinical research.
    Schaeffer MH; Krantz DS; Wichman A; Masur H; Reed E; Vinicky JK
    Am J Med; 1996 Mar; 100(3):261-8. PubMed ID: 8629670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the ability of clinical research participants to comprehend informed consent form.
    Bhansali S; Shafiq N; Malhotra S; Pandhi P; Singh I; Venkateshan SP; Siddhu S; Sharma YP; Talwar KK
    Contemp Clin Trials; 2009 Sep; 30(5):427-30. PubMed ID: 19341820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial.
    Harrison K; Vlahov D; Jones K; Charron K; Clements ML
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):386-90. PubMed ID: 7552502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of the comprehension of written information given to healthy volunteers in biomedical research: a single-blind randomized controlled study.
    Paris A; Nogueira da Gama Chaves D; Cornu C; Maison P; Salvat-Mélis M; Ribuot C; Brandt C; Bosson JL; Hommel M; Cracowski JL
    Fundam Clin Pharmacol; 2007 Apr; 21(2):207-14. PubMed ID: 17391294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic misconception in early phase gene transfer trials.
    Henderson GE; Easter MM; Zimmer C; King NM; Davis AM; Rothschild BB; Churchill LR; Wilfond BS; Nelson DK
    Soc Sci Med; 2006 Jan; 62(1):239-53. PubMed ID: 16000230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The problem with optimism in clinical trials.
    Jansen LA
    IRB; 2006; 28(4):13-9. PubMed ID: 17036434
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of tool for the assessment of comprehension of informed consent form in healthy volunteers participating in first-in-human studies.
    Arora A; Rajagopalan S; Shafiq N; Pandhi P; Bhalla A; Dhibar DP; Malhotra S
    Contemp Clin Trials; 2011 Nov; 32(6):814-7. PubMed ID: 21664491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
    Vanderpool HY
    Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are subjects satisfied with the informed consent process? A survey of research participants.
    Pope JE; Tingey DP; Arnold JM; Hong P; Ouimet JM; Krizova A
    J Rheumatol; 2003 Apr; 30(4):815-24. PubMed ID: 12672205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new brief instrument for assessing decisional capacity for clinical research.
    Jeste DV; Palmer BW; Appelbaum PS; Golshan S; Glorioso D; Dunn LB; Kim K; Meeks T; Kraemer HC
    Arch Gen Psychiatry; 2007 Aug; 64(8):966-74. PubMed ID: 17679641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic misconception and the appreciation of risks in clinical trials.
    Lidz CW; Appelbaum PS; Grisso T; Renaud M
    Soc Sci Med; 2004 May; 58(9):1689-97. PubMed ID: 14990370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.